Sign inGet started

Thompson Alexis A.

Insider CIK 1851895 · GBT Director

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
GBT Global Blood Therapeutics, D To issuer deriv2022-10-052022-10-061,412— $00SEC↗
GBT Global Blood Therapeutics, D To issuer deriv2022-10-052022-10-0611,200— $00SEC↗
GBT Global Blood Therapeutics, D To issuer deriv2022-10-052022-10-063,600— $00SEC↗
GBT Global Blood Therapeutics, D To issuer deriv2022-10-052022-10-064,800— $00SEC↗
GBT Global Blood Therapeutics, D To issuer deriv2022-10-052022-10-065,600— $00SEC↗
GBT Global Blood Therapeutics, D To issuer2022-10-052022-10-063,308— $00SEC↗
GBT Global Blood Therapeutics, A Award deriv2022-06-142022-06-163,600— $03,600SEC↗
GBT Global Blood Therapeutics, M Exercise deriv2022-06-142022-06-16908— $00SEC↗
GBT Global Blood Therapeutics, A Award deriv2022-06-142022-06-165,600— $05,600SEC↗
GBT Global Blood Therapeutics, M Exercise2022-06-142022-06-16908— $03,308SEC↗
GBT Global Blood Therapeutics, M Exercise deriv2022-03-172022-03-182,400— $04,800SEC↗
GBT Global Blood Therapeutics, M Exercise2022-03-172022-03-182,400— $02,400SEC↗
GBT Global Blood Therapeutics, A Award deriv2021-06-172021-06-21908— $0908SEC↗
GBT Global Blood Therapeutics, A Award deriv2021-06-172021-06-211,412— $01,412SEC↗
GBT Global Blood Therapeutics, A Award deriv2021-03-172021-03-197,200— $07,200SEC↗
GBT Global Blood Therapeutics, A Award deriv2021-03-172021-03-1911,200— $011,200SEC↗